The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale

Author： Lamers Leida M. Groot Carin A. Uyl-de Buijt Ivonne

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.7, 2007-01, pp. : 591-603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estimating the Relationship between Preference-Based Generic Utility Instruments and Disease-Specific Quality-of-Life Measures in Severe Chronic Constipation: Challenges in Practice

By Parker Mark Haycox Alan Graves Jane

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 719-730

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis: Cost-Utility Analysis Using a Markov Model

By Kreck Simon Klaus Jochen

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 311-328

Adis International

Access to resources Recommend Favorite

Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index

By Xie Feng Pullenayegum Eleanor M. Li Shu-Chuen Hopkins Robert Thumboo Julian Lo Ngai-Nung

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 873-878

Blackwell Publishing

Access to resources Recommend Favorite

Cost-benefit or cost-utility analysis?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Treatment of Advanced Parkinson's Disease in the United States: A Cost-Utility Model

By Groenendaal Huybert

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 789-798

Adis International

Access to resources Recommend Favorite